Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Stomach Neoplasms 1Neoplasms 1Lymphoma 1Leukemia 1Hematologic Diseases 1Colorectal Neoplasms 1

Interventions

pegylated granulocyte colony-stimulating factor 4entecavir 3Granulocyte Colony-Stimulating Factor 3Cyclophosphamide 3Brentuximab Vedotin 3Aprepitant 3Vinblastine 2Prednisolone 2Doxorubicin 2Dexamethasone 2rasburicase 1prednylidene 1plerixafor 1peginterferon alfa-2b 1pegfilgrastim 1golimumab 1fludarabine phosphate 1fludarabine 1fluarix 1ferrous succinate 1dexamethasone 21-phosphate 1arexvy 1abrysvo 1Zidovudine 1Water 1Watchful Waiting 1Vindesine 1Vincristine 1Valproic Acid 1Urate Oxidase 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 4 × Lymphoma × Water × Clear all
NCT02095951 2018-12-19

Preemptive Ethanol Lock Therapy in Pediatric Bloodstream Infection

Children's Hospital of Michigan

Phase 4 Completed
30 enrolled 8 charts
LymphoidOther hematologic neoplasm

Hematologic Diseases, Leukemia, Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡